This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or manage your own preferences.
Erysipelas
Published October 30, 2024
N Engl J Med 2024;391:1632
DOI: 10.1056/NEJMicm2404869
Abstract
A 44-year-old man with infliximab-treated Crohn’s disease presented with a 2-day history of rash on his face. Well-demarcated, warm, erythematous, confluent plaques were seen across the cheeks, nose, and glabella.
Continue reading this article
Select an option below:
Create your account to get 2 free subscriber-only articles each month.
Get Free Access Now Subscribe For Full AccessNotes
This article was updated on October 31, 2024, at NEJM.org.
Information & Authors
Information
Published In
Copyright
Copyright © 2024 Massachusetts Medical Society. All rights reserved.
For personal use only. Any commercial reuse of NEJM Group content requires permission.
History
Published online: October 30, 2024
Published in issue: October 31, 2024
Topics
Authors
Affiliations
Yale School of Medicine, New Haven, CT
nathan.wood@yale.edu
nathan.wood@yale.edu
Metrics & Citations
Metrics
Altmetrics
Citations
Export citation
Select the format you want to export the citation of this publication.
